Vertex Pharmaceuticals Stock Jumps as Non-Opioid Painkiller Gets FDA Approval
1. Vertex's Journavx is FDA-approved, first non-opioid painkiller in 20 years. 2. Journavx priced at $15.50 per 50mg pill for U.S. market. 3. FDA approval boosts VRTX shares by nearly 7% on announcement day. 4. CEO claims Journavx can change acute pain management standards. 5. Journavx offers pain relief without addictive potential.